New consecutive high-dose chemotherapy modality with fractionated blood stem cell support in the treatment of high-risk pediatric solid tumors: a feasibility study.
Kajiume T, Kawano Y, Takaue Y, Abe T, Watanabe T, Okamoto Y, Makimoto A, Suenaga K, Suzuya H, Sato J, Yokobayashi A, Hashimoto T, Yoshida K, Ishibashi H, Takehara H, Tashiro S, Kuroda Y.
Kajiume T, et al. Among authors: sato j.
Bone Marrow Transplant. 1998 Jan;21(2):147-51. doi: 10.1038/sj.bmt.1701061.
Bone Marrow Transplant. 1998.
PMID: 9489631
Clinical Trial.